Europe's IMI Sets Pace for Public/Private Partnerships in Pharmaceutical Development
A recent PharmaTimes article highlighted the efforts of the largest public/private partnership in the pharmaceutical industry, Europe’s Innovative Medicines Initiative (IMI). The IMI, jointly funded for 2 billion euros by the European Commission and the industry group, the European Federation of Pharmaceutical Industries and Associations (EFPIA), seeks to address the development and delivery issues for …
Europe's IMI Sets Pace for Public/Private Partnerships in Pharmaceutical Development Read More »
